Systemic lidocaine or mexiletine for neuropathic pain

American Family Physician

Volumn 74, Issue 1, 2006, Pages 79-80

  Ebell, Mark H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIDOCAINE; MEXILETINE; PLACEBO;

ANALGESIA; CLINICAL TRIAL; COMPLEX REGIONAL PAIN SYNDROME; DRUG EFFICACY; DRUG SAFETY; FIBROMYALGIA; HUMAN; NEUROPATHIC PAIN; NOTE; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; PHANTOM PAIN; SPINAL CORD INJURY; TRIGEMINUS NEURALGIA; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, ORAL; ANESTHETICS; EVIDENCE-BASED MEDICINE; HUMANS; INFUSIONS, INTRAVENOUS; LIDOCAINE; MEXILETINE; NEURALGIA; PRACTICE GUIDELINES;

EID: 33745911603     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Note

References (2)

1. Reflex Sympathetic Dystrophy Syndrome Association. Clinical practice guidelines (second edition) for the diagnosis, treatment, and management of reflex sympathetic dystrophy/complex regional pain syndrome (RSD/CRPS). Milford, Conn.: Reflex Sympathetic Dystrophy Syndrome Association, 2002.
2. Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003;60:1524-34.